You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 4
  • EPV066/#382 Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101: an open-label, single arm, phase II clinical trial

Citation Tools

Article menu

Download PDFPDF

E-Posters
E-Poster Viewing
EPV066/#382 Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101: an open-label, single arm, phase II clinical trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Zou D, Wang H, Shu J, et al
EPV066/#382 Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101: an open-label, single arm, phase II clinical trial
International Journal of Gynecologic Cancer 2021;31:A55.